Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1965 3
1966 8
1967 4
1968 5
1969 6
1970 1
1971 4
1972 6
1973 8
1974 10
1975 13
1976 9
1977 13
1978 12
1979 22
1980 14
1981 12
1982 24
1983 27
1984 14
1985 21
1986 15
1987 21
1988 25
1989 32
1990 31
1991 31
1992 34
1993 41
1994 42
1995 51
1996 49
1997 27
1998 35
1999 45
2000 29
2001 20
2002 21
2003 21
2004 18
2005 20
2006 15
2007 14
2008 16
2009 12
2010 13
2011 22
2012 15
2013 20
2014 16
2015 14
2016 24
2017 23
2018 36
2019 27
2020 29
2021 32
2022 31
2023 4
Text availability
Article attribute
Article type
Publication date

Search Results

1,152 results
Results by year
Filters applied: . Clear all
Page 1
Rosacea management: A comprehensive review.
Sharma A, Kroumpouzos G, Kassir M, Galadari H, Goren A, Grabbe S, Goldust M. Sharma A, et al. J Cosmet Dermatol. 2022 May;21(5):1895-1904. doi: 10.1111/jocd.14816. Epub 2022 Feb 14. J Cosmet Dermatol. 2022. PMID: 35104917 Review.
Light therapies such as intense pulsed light and pulsed dye laser are best used for the erythemato-telangiectatic type. Topical brimonidine, oxymetazoline, ivermectin, tacrolimus, pimecrolimus, low-dose modified-release tetracyclines and botulinum toxin are the new additio …
Light therapies such as intense pulsed light and pulsed dye laser are best used for the erythemato-telangiectatic type. Topical brimonidine, …
Uses of eye drops in dermatology, literature review.
Sarsik SM, El-Amawy HS. Sarsik SM, et al. J Dermatolog Treat. 2022 Sep;33(6):2758-2770. doi: 10.1080/09546634.2022.2079598. Epub 2022 Jun 2. J Dermatolog Treat. 2022. PMID: 35652324 Review.
The FDA-approved and off-label applications of various eye drops used as topical treatments in dermatological clinical practice were highlighted in this review.Methodology: A thorough PubMed and Google Scholar library search using various combinations of the keywords (Eye drop, o …
The FDA-approved and off-label applications of various eye drops used as topical treatments in dermatological clinical practice were highlig …
Topical Nasal Decongestant Oxymetazoline: Safety Considerations for Perioperative Pediatric Use.
Cartabuke R, Tobias JD, Jatana KR; SECTION ON ANESTHESIOLOGY AND PAIN MEDICINE, SECTION ON OTOLARYNGOLOGY–HEAD AND NECK SURGERY. Cartabuke R, et al. Pediatrics. 2021 Nov 1;148(5):e2021054271. doi: 10.1542/peds.2021-054271. Epub 2021 Oct 4. Pediatrics. 2021. PMID: 34607935
The over-the-counter nasal decongestant oxymetazoline (eg, Afrin) is used in the pediatric population for a variety of conditions in the operating room setting. ...Further studies are needed to understand the systemic absorption and effects in children in both nonsurgical …
The over-the-counter nasal decongestant oxymetazoline (eg, Afrin) is used in the pediatric population for a variety of conditions in …
Oxymetazoline-Induced Asthma.
Shah S, Patel K, Gambhir HS. Shah S, et al. Am J Ther. 2018 Nov/Dec;25(6):e681-e682. doi: 10.1097/MJT.0000000000000628. Am J Ther. 2018. PMID: 28901959 No abstract available.
Difference in vasoconstrictors: oxymetazoline vs. brimonidine.
Okwundu N, Cline A, Feldman SR. Okwundu N, et al. J Dermatolog Treat. 2021 Mar;32(2):137-143. doi: 10.1080/09546634.2019.1639606. Epub 2019 Aug 12. J Dermatolog Treat. 2021. PMID: 31294643 Review.
OBJECTIVE: Topical oxymetazoline and brimonidine are the only medications approved for treating persistent facial erythema of rosacea. This review aims to investigate the efficacy, safety, pharmacodynamics, and pharmacokinetic properties of oxymetazoline and brimoni …
OBJECTIVE: Topical oxymetazoline and brimonidine are the only medications approved for treating persistent facial erythema of rosacea …
Oxymetazoline.
Covington TR, Pau AK. Covington TR, et al. Am Pharm. 1985 May;NS25(5):21-6. doi: 10.1016/s0160-3450(16)32692-7. Am Pharm. 1985. PMID: 4003266 No abstract available.
Oxymetazoline for Ptosis.
Bradley EA, Bradley DJ. Bradley EA, et al. JAMA Ophthalmol. 2020 Nov 1;138(11):1176-1177. doi: 10.1001/jamaophthalmol.2020.3833. JAMA Ophthalmol. 2020. PMID: 33001145 No abstract available.
Role of Topical Oxymetazoline for Management of Erythematotelangiectatic Rosacea.
Hoover RM, Erramouspe J. Hoover RM, et al. Ann Pharmacother. 2018 Mar;52(3):263-267. doi: 10.1177/1060028017740139. Epub 2017 Nov 2. Ann Pharmacother. 2018. PMID: 29094614 Review.
Current data suggest that oxymetazoline is similar in safety and efficacy to brimonidine. Head-to-head comparisons of topical alpha-agonists for erythema caused by rosacea are needed. CONCLUSION: The topical alpha-agonist, oxymetazoline, is safe and effective for re …
Current data suggest that oxymetazoline is similar in safety and efficacy to brimonidine. Head-to-head comparisons of topical alpha-a …
Oxymetazoline hydrochloride cream for facial erythema associated with rosacea.
Patel NU, Shukla S, Zaki J, Feldman SR. Patel NU, et al. Expert Rev Clin Pharmacol. 2017 Oct;10(10):1049-1054. doi: 10.1080/17512433.2017.1370370. Epub 2017 Aug 24. Expert Rev Clin Pharmacol. 2017. PMID: 28837365 Review.
A primarily alpha-1a agonist, oxymetazoline hydrochloride (HCl) is thought to diminish erythema through vasoconstriction. ...As further evidence becomes available, the real-world clinical potential of topical oxymetazoline cream will become clearer....
A primarily alpha-1a agonist, oxymetazoline hydrochloride (HCl) is thought to diminish erythema through vasoconstriction. ...As furth …
1,152 results